May 25, 2022
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attention: Tyler Howes
| Re: | Standard BioTools Inc. |
Registration Statement on Form S-3
Filed May 17, 2022
File No. 333-265010
Acceleration Request
Requested Date: May 26, 2022
Requested Time: 4:00 P.M. Eastern Time, or as soon thereafter as practicable
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Standard BioTools Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-265010) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Zachary Myers at (858) 350-2350.
* * * *
| Sincerely, |
| Standard BioTools Inc. |
| /s/ Nicholas Khadder |
| Nicholas Khadder |
| Senior Vice President, General Counsel, and Secretary |
| cc: | Michael Egholm, President and Chief Executive Officer, Standard BioTools Inc. |
Robert F. Kornegay, Wilson Sonsini Goodrich & Rosati, P.C.
Zachary Myers, Wilson Sonsini Goodrich & Rosati, P.C.